Prevalence of Nonalcoholic Fatty Liver Disease at a Tertiary Care Center in Saudi Arabia

被引:0
作者
Hussein, Ghada [1 ]
Saud, Aljoharah A. Al [2 ]
Bashandi, Abdulelah A. [2 ]
Almousallam, Mohammed M. [2 ]
Alshihri, Reem M. [2 ]
Almousallam, Osama M. [2 ]
Binsalamah, Ibrahim M. [2 ]
Alendijani, Yaser [3 ]
机构
[1] King Faisal Specialist Hosp & Res Ctr, Family Med, Riyadh, Saudi Arabia
[2] Alfaisal Univ, Coll Med, Family Med & Polyclin, Riyadh, Saudi Arabia
[3] King Faisal Specialist Hosp & Res Ctr, Family Med & Polyclin, Riyadh, Saudi Arabia
关键词
nonalcoholic fatty liver disease (nafld); obesity; family medicine; fatty liver; fib-4; nafld; NAFLD;
D O I
10.7759/cureus.47896
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To determine the prevalence of nonalcoholic fatty liver disease (NAFLD) in patients who received abdominal imaging and to assess the clinical and metabolic characteristics of NAFLD.Methods: This is a retrospective study of 500 family medicine patients (aged 18 years and older) who completed abdominal imaging at King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia, from January 2016 through June 2020.Results: The patients enrolled had a mean age of 49.41 +/- 14.80 years, with 300 females and 349 of Saudi nationality. The mean body mass index (BMI) was 29.43 +/- 6.61 kg/m2, while 373 of the enrolled subjects were either overweight or obese. Half of our patients had some form of fatty liver in the imaging results. Regarding chronic medical conditions, 33.4%, 31.4%, and 29.4% had a history of hypertension, type 2 diabetes mellitus (DM2), and dyslipidemia, respectively. The mean Fibrosis-4 (FIB-4) index was 0.94 +/- 0.72. Body mass index was higher among fatty liver patients (p = 0.001). Hypertension, coronary artery disease, dyslipidemia, and DM2 were more common in the fatty liver group.Conclusion: Our findings reiterate the significance of obesity and the coexistence of cardiovascular risk factors in NAFLD. Further studies are needed to corroborate and expand our findings, enabling more refined strategies for the prevention, risk prediction, early detection, and management of NAFLD.
引用
收藏
页数:9
相关论文
共 13 条
[1]   Prevalence and predictors of non-alcoholic fatty liver disease in tertiary care hospital of Taif, Saudi Arabia: A retrospective study [J].
Alamri, Abdulhakeem S. ;
Alhomrani, Majid ;
Alsanie, Walaa F. ;
Alghamdi, Ahmad Joman ;
Alghamdi, Zaher M. ;
Al-Subaie, Abdualmohsen A. ;
Alharthi, Yasser A. ;
Alqurashi, Hesham H. ;
Asdaq, Syed Mohammed Basheeruddin .
SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2021, 28 (09) :4921-4925
[2]   Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Saudi Arabia: Systematic Review and Meta-analysis [J].
Alenezi, Yusef M. ;
Harris, Rebecca ;
Morling, Joanne ;
Card, Tim .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (06)
[3]   Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) Registry [J].
Alswat, Khalid ;
Sanai, Faisal M. ;
Al-hamoudi, Waleed ;
Ismail, Mona ;
Dahlan, Yaser ;
AlGhamdi, Hamdan Saleh ;
Altraif, Ibrahim ;
Alalwan, Abduljaleel ;
Babatin, Mohamed M. A. ;
Alqahtani, Saleh A. .
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 :1167-1175
[4]  
Alswat K, 2018, SAUDI J GASTROENTERO, V24, P211, DOI [10.4103/sjg.sjg_122_18, 10.4103/sjg.SJG_122_18]
[5]   Position statement on the diagnosis and management of non-alcoholic fatty liver disease [J].
Alswat, Khalid A. ;
Fallatah, Hind I. ;
Al-Judaibi, Bandar ;
Elsiesy, Hussien A. ;
Al-Hamoudi, Waleed K. ;
Qutub, Adel N. ;
Alturaify, Naif ;
Al-Osaimi, Abdullah .
SAUDI MEDICAL JOURNAL, 2019, 40 (06) :531-540
[6]   American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD) [J].
Cusi, Kenneth ;
Isaacs, Scott ;
Barb, Diana ;
Basu, Rita ;
Caprio, Sonia ;
Garvey, W. Timothy ;
Kashyap, Sangeeta ;
Mechanick, Jeffrey I. ;
Mouzaki, Marialena ;
Nadolsky, Karl ;
Rinella, Mary E. ;
Vos, Miriam B. ;
Younossi, Zobair .
ENDOCRINE PRACTICE, 2022, 28 (05) :528-562
[7]   Prevalence and clinical characteristics of NAFLD in chronic liver disease patients from King Abdulaziz University Hospital, Jeddah [J].
Fallatah, Hind Ibrahim ;
Al-Dabbagh, Ammar ;
Hiejazi, Mohammead T. ;
Hanbazazah, Sulaiman A. A. ;
Hussein, Ali O. ;
Al-Sahafi, Majed A. ;
Akbar, Hisham O. .
SAUDI JOURNAL OF MEDICINE & MEDICAL SCIENCES, 2020, 8 (02) :118-124
[8]   NAFLD and cardiovascular diseases: a clinical review [J].
Kasper, Philipp ;
Martin, Anna ;
Lang, Sonja ;
Kuetting, Fabian ;
Goeser, Tobias ;
Demir, Muenevver ;
Steffen, Hans-Michael .
CLINICAL RESEARCH IN CARDIOLOGY, 2021, 110 (07) :921-937
[9]   ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries [J].
Kwo, Paul Y. ;
Cohen, Stanley M. ;
Lim, Joseph K. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (01) :18-35
[10]   Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: A systematic review [J].
Lee, Jenny ;
Vali, Yasaman ;
Boursier, Jerome ;
Spijker, Rene ;
Anstee, Quentin M. ;
Bossuyt, Patrick M. ;
Zafarmand, Mohammad H. .
LIVER INTERNATIONAL, 2021, 41 (02) :261-270